Authors presented the case of a 48-year-old woman with rheumatoid arthritis, newly diagnosed microscopic polyangiitis, and a recent COVID-19 infection who stopped taking immunosuppressive therapy.
Researchers evaluated the association between the use of hydroxychloroquine and risk of developing heart failure in rheumatoid arthritis.
In pulmonary arterial hypertension, high plasma levels of hepatic growth factor are associated with the right heart maladaptive phenotype and are incremental to the REVEAL score for the prediction of patient outcomes.
Researchers evaluated the association between serum urate, gout, and cardiovascular comorbidities, using data from the UK Biobank.
In patients with pulmonary hypertension undergoing rehabilitation, greater inclusion of outcome measures is needed to facilitate accurate assessment of the wider effect this intervention.
Patients with pulmonary hypertension exhibited a reduced exercise capacity under hypoxic conditions, although with high inter-individual variability.
Although higher body mass index is causally associated with higher pulmonary artery pressure, it is not associated with pulmonary vascular remodeling.
In patients with CTEPH, lung perfused blood volume and mean pulmonary artery enhancement could be indicators of hemodynamics.
With close monitoring, the use of oral add-on treatment with selexipag in children with pulmonary arterial hypertension was safe and well tolerated.
In patients with pulmonary arterial hypertension, high levels of platelet endothelial cell adhesion molecule 1 (PECAM-1) are associated with less improvement in 6-minute walk distance and may also be predictive of response to treprostinil.
